Biotech Galectin Therapeutics Announces the End of Enrollment of NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Liver Cirrhosis Caused by Non-Alcoholic Steatohepatitis January 5, 2023
Biotech Genprex Signs Exclusive License to Additional Diabetes Technology with the University of Pittsburgh January 5, 2023
Biotech CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference January 5, 2023
Biotech EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines January 5, 2023